[Atherosclerosis, with special reference to vitamin E].
The relationship between atherosclerosis and fat soluble vitamin, especially vitamin E is reviewed on the basis of oxidised modification of low density lipoprotein (LDL). Data now support the notion that the oxidised LDL is present in the blood and arterial wall and antioxidant drugs such as probucol and vitamin E, beta-carotene, may prevent the progression of atherosclerosis. LDL alpha-tocopherol levels are generally correlated to the plasma concentrations and supplementation with alpha-tocopherol increases its content in LDL. There is a significant correlation between the LDL alpha-tocopherol level and the resistance to oxidative modification. Epidemiological data also shows the relation between low levels of plasma vitamin E and the increased incidence of coronary heart disease. Clinical application of vitamin E should be clarified in detail to inhibit the progression of atherosclerosis.
Nakamura
H
H
1st Dept. of Medicine, National Defence Medical College.
Suzukawa
M
M
D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D008077:Lipoproteins, LDL / Q000097:blood; D014810:Vitamin E / Q000627:therapeutic use*
D008077:Lipoproteins, LDL; D014810:Vitamin E